CSIMarket Company Name, Ticker, Suppliers, else..
 
Telix Pharmaceuticals Ltd  (NASDAQ: TLX)
 
Price: $10.8800 $-0.21 -1.894%
Day's High: $10.960000038146973 Week Perf: -2.25 %
Day's Low: $ 10.80 30 Day Perf: 8.58 %
Volume (M): 113,952 52 Wk High: $ 12.48
Volume (M$): $ 0 52 Wk Avg: $9.54
Open: $10.94 52 Wk Low: $6.28



 Market Capitalization (Millions $) 3,676
 Shares Outstanding (Millions) 338
 Employees 1,120
 Revenues (TTM) (Millions $) 803
 Net Income (TTM) (Millions $) -7
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


Telix Pharmaceuticals Limited, incorporated in Australia in January 2017, is listed on the Australian Securities Exchange and the Nasdaq Global Select Market through ordinary shares and American depositary shares, respectively. The company prepares consolidated financial statements in accordance with International Financial Reporting Standards and operates in the pharmaceutical industry, focusing on the commercialization and development of product candidates including Pixclara® (TLX101-Px) and Zircaix® (TLX250-Px).


   Company Address: 55 Flemington Road North Melbourne 3051
   Company Phone Number: 9093 3855   Stock Exchange / Ticker: NASDAQ TLX


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 4.58
Price to Sales (Expected) -
Price to Book 8.85
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.27
Working Capital Ratio 0.34
Leverage Ratio (MRQ) 1.8
Total Debt to Equity 0.95
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) 0 $
Revenues (TTM) 2.38 $
Cash Flow (TTM) -
Cash 0.44 $
Book Value 1.23 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 717,355
Net Income per Employee (TTM) -6,362
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.75

Profitability Ratios Current
Gross Margin (MRQ) 53.08 %
Operating Margin (MRQ) 3.71 %
Net Margin (MRQ) -0.89 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Telix Pharmaceuticals Ltd's Segments
segments    100.04 % of total Revenue
Precision Medicine    77.41 % of total Revenue
Therapeutics    1.15 % of total Revenue
Manufacturing Solutions    21.48 % of total Revenue
Inter-eliminations    8.52 % of total Revenue
China    1.22 % of total Revenue
United States    97.69 % of total Revenue
Other countries    1.13 % of total Revenue
At a point in time Precision Medicine    77.37 % of total Revenue
At a point in time Manufacturing Solutions    20.42 % of total Revenue
At a point in time Therapeutics    0.01 % of total Revenue
Over time Manufacturing Solutions    1.06 % of total Revenue
Over time Therapeutics    1.14 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.